The supply and demand imbalances caused by the COVID-19 pandemic has created a surge in substandard and falsified treatments. USP is working with public health organizations, pharmacopeias, manufacturers and regulators in the U.S. and around the world to combat poor-quality medicines and build the public’s trust in COVID-19 treatments. Our resources and tools help ensure the quality of medical products for drug ingredients and finished products. USP is committed to strengthening the supply of trusted, quality medicines needed to fight the pandemic.
A Concise Quality Control Guide on Essential Drugs and other Medicines: COVID-19 Special Issue